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a b s t r a c t
Introduction: The objective of this study is to evaluate the survival and glucose-induced insulin secretion
of rat-derived insulinoma cells (INS-1) from their aggregates incorporating different size of gelatin
hydrogel microspheres comparing with microspheres-free cell aggregates.
Methods: The gelatin hydrogel microspheres were prepared by the conventional w/o emulsion method.
The INS-1 cells were cultured in a V-bottomed well, combining with or without the gelatin hydrogel
microspheres to form their aggregates with or without microspheres.
Results: When the cell viability, the live cell number, the reductase activity, and the insulin secretion of
cell aggregates were evaluated 7 or 14 days after incubation, the cell aggregates incorporating gelatin
hydrogel microspheres showed higher cell viability, reductase activity and a larger number of live cells.
The cell aggregates incorporating larger size and number of gelatin hydrogel microspheres secreted a
larger amount of insulin, compared with those incorporating smaller size and number of microspheres or
without microspheres.
Conclusion: It is conceivable that the incorporation of gelatin hydrogel microspheres in cell aggregates is
promising to improve their survival and insulin secretion function.
© 2018, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
1. Introduction
Islet transplantation has been investigated as a treatment of
type 1 diabetes for patients with insufﬁcient glucose control [1e3].
However, a big problem of islet transplantation therapy is the
serious donor shortage [4e6]. To circumvent this issue, it has been
reported to reconstitute islet-like aggregates of insulin secreting
cells [7,8]. However, for this approach, when the cell aggregates
become larger than 200 mm in diameter, the cells in the center of
cell aggregates tend to die because of a lack of oxygen and nutrients
supply [9,10]. It is well known that insulin secreting cells show
a decreased function of insulin secretion under a hypoxic
environment [11,12]. Therefore, to achieve sufﬁcient therapeutic
effect with the insulin secreting cell aggregates, it is necessary to
develop a method for the promotion of oxygen and nutrients
supply.
Previous studies demonstrated that the incorporation of
gelatin hydrogel microspheres in mesenchymal stem cells (MSC)
aggregates enabled the cells to improve the viability, proliferation
and osteogenic differentiation. This is because the microspheres
improved the state of oxygen and nutrients supply for cells [13,14].
In this study, the gelatin hydrogel microspheres technology was
introduced to insulin secreting cell aggregates to assess the
cell viability and insulin secretion function comparing with
microspheres-free cell aggregates. Gelatin hydrogel microspheres
with different sizes were prepared by the conventional w/o
emulsion method previously reported [15]. Rat insulinoma cells
(INS-1), the model of insulin secreting cells, were incubated with
or without the gelatin hydrogel microspheres in a V-bottomed
well to form the cell aggregates with or without the microspheres.
We examined the effect of microspheres size and number on the
cell viability, reductase activity, and insulin secretion ability in the
aggregates.
Abbreviations: INS-1, insulinoma; MSC, mesenchymal stem cell.
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2. Materials and methods
2.1. Preparation of gelatin hydrogel microspheres
Gelatin hydrogel microspheres were prepared by the chemical
cross-linking of gelatin in awater-in-oil emulsion state according to
the method previously reported [15]. Brieﬂy, an aqueous solution
(20 ml) of 10 wt% gelatin (isoionic point 5.0 (pI 5), weight-averaged
molecular weight ¼ 1,00,000, Nitta Gelatin Inc., Osaka, Japan) was
preheated at 40 C, and then added dropwise into 600 ml of olive
oil (Wako Pure Chemical Industries Ltd., Osaka, Japan) at 40 C,
followed by stirring at 200 rpm for 10 min to prepare a water-in-oil
emulsion. The emulsion temperature was decreased to 4 C for the
natural gelation of gelatin solution to obtain non-crosslinked mi-
crospheres. The resulting microspheres were washed three times
with cold acetone in combination with centrifugation (5000 rpm.,
4 C, 5 min) to completely exclude the residual oil. Then, they were
fractionated by size using sieves with apertures of 20, 32, and
53 mm (Iida Seisakusyo Ltd., Osaka, Japan) and air dried at 4 C. The
non-crosslinked and dried gelatin microspheres (200 mg) were
treated in a vacuum oven at 140 C and 0.1 Torr for 48 h for the
dehydrothermal crosslinking of gelatin. Pictures of gelatin hydrogel
microspheres in a dispersed state in RPMImedium 1640 containing
L-glutamine (Invitrogen Ltd., Carlsbad, CA), were taken with a light
microscope (BZ-X710, KEYENCE Corp., Osaka, Japan). The size of
100 microspheres for each sample was measured using the com-
puter program of microscope (BZ-X710) to calculate the average
diameter.
2.2. Preparation of INS-1 cell aggregates with or without gelatin
hydrogel microspheres
A cell line 832/13, derived from INS-1 rat insulinoma cells, was
obtained from Dr. Christopher B. Newgard (Duke University Med-
ical Center, Durham, NC) [16]. Cells were grown in RPMI medium
1640 containing L-glutamine (Invitrogen Ltd.), 1 mM sodium py-
ruvate (Invitrogen Ltd.), 10 mM HEPES (Invitrogen Ltd.), 10 vol%
heat-inactivated fetal bovine serum (Thermo Fisher Scientiﬁc Inc.,
Waltham, MA), 55 mM 2-mercaptoethanol (Invitrogen Ltd.), 100 IU/
ml penicillin (Gibco, Grand Island, NY), and 100 mg/ml streptomycin
(Gibco). Cells were cultured in a humidiﬁed atmosphere containing
5% CO2/95% air at 37 C.
Gelatin hydrogel microspheres and INS-1 cells were separately
suspended in the culture medium under different conditions
(Table 1). Gelatin microsphere suspensions (100 ml) were added to
each well of a 96-well culture plate with V-bottomed wells, fol-
lowed by 50 ml of INS-1 cell suspensions at the initial density of
1.0  103 or 1.0  104 cells/well and 1.0  101, 0.5  102, 1.0 102 or
1.0  103 microspheres/well. The cells/microspheres number ratio
is 10/1, 100/1, or 200/1. Pictures of INS-1 cell aggregates with or
without gelatin hydrogel microspheres were taken with the mi-
croscope as described above.
2.3. Evaluation of cell viability, reductase activity, and live cell
number
The number of live cells in INS-1 cell aggregates with or without
gelatin hydrogel microspheres was determined by trypan-blue
staining. After 7 or 14 days incubation, cell aggregates were
collected into a 1.5 ml microtube and washed by 100 ml of
phosphate-buffered saline solution (PBS, Gibco) once. After
centrifugation and the supernatants removal, the aggregate pellets
were incubated in 100 ml of trypsineEDTA solution (SigmaeAldrich
Company Ltd., St. Louis, MO) for 15 min at 37 C. Following the
incubation, 100 ml of culture mediumwas added to stop the trypsin
action. Live cells in the cell suspension were counted by a cell
counter (Countess II FL, Thermo Fisher Scientiﬁc Inc.). Live/dead
assays were conducted using a Live/Dead Viability/Cytotoxicity
Assay (Invitrogen) according to the manufacturer's protocol. The
cell aggregates were rinsed once with PBS 7 or 14 days after incu-
bation, and then incubatedwith themixed solution of 2mM calcein
AM and 4 mM ethidium homodimer-1 solution in PBS for 15 min at
room temperature in the dark, followed by observation using a
microscope (BX-X710).
Reductase activity of INS-1 cell aggregates with or without
gelatin hydrogel microspheres was determined by colorimetric
assay using water-soluble tetrazolium salt as one measure to assess
a cell metabolic activity. After 7 or 14 days incubation, cell aggre-
gates were collected into a well of 96 well ﬂat-bottomed plate and
the culture medium was adjusted 100 ml in each well. WST-8 re-
agent (10 ml, Dojindo Laboratories, Kumamoto, Japan) was added
into each well, and then cell aggregates were incubated for 4 h at
37 C. After the incubation, the absorbance at 450 nm was
measured by SpectraMax M2/M2e Microplate Reader (Molecular
Devices, LLC, CA). The reductase activity was normalized by the live
cell number.
2.4. Evaluation of glucose-induced insulin secretion
After 7 or 14 days incubation, INS-1 cell aggregates with or
without gelatin hydrogel microspheres were transferred to each
well of a 12 mm Transwell (#3402, Coring Inc. Corning, NY) and
washed once by PBS. Then, Krebs-Ringer-bicarbonate HEPES (KRB)
buffer solution containing 10 mM glucose [16] was added to each
well, and the cell aggregates were incubated for 1 h at 37 C. The
concentration of secreted insulin in the supernatants was
measured by ELISA kit (Rat Insulin ELISA KIT, Shibayagi Co. Ltd.,
Gunma, Japan). The insulin secretion was normalized by the live
cell number.
2.5. Statistical analysis
All the statistical data are expressed as mean ± standard error of
the mean (SEM). The data were analyzed using the Tukey's test and
the statistical signiﬁcance was accepted at P < 0.05 or 0.01.
3. Result
3.1. Characterization of gelatin hydrogel microspheres
Fig. 1 shows the microscopic images of gelatin hydrogel micro-
spheres. Themicrospheres had spherical shape and smooth surface.
Table 1
Preparation conditions of INS-1 cells aggregate with or without gelatin micro-
spheres incorporation





Size of gelatin hydrogel
microspheres (mm)
a 1.0  103 0 —
b 1.0  103 1.0  101 46.0 ± 14.0
c 1.0  103 1.0  101 82.0 ± 18.0
d 1.0  104 0 —
e 1.0  104 1.0  102 22.0 ± 9.0
f 1.0  104 1.0  103 22.0 ± 9.0
g 1.0  104 1.0  102 46.0 ± 14.0
h 1.0  104 0.5  102 82.0 ± 18.0
i 1.0  104 1.0  102 82.0 ± 18.0
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The size of microspheres in the swollen condition in the culture
medium was 22.0 ± 9.0 (small), 46.0 ± 14.0 (middle) and
82.0 ± 18.0 mm (large).
3.2. Characterization of INS-1 aggregates with and without gelatin
hydrogel microspheres
Table 1 shows the preparation condition of cell aggregate using
middle or large microspheres. Small gelatin hydrogel microspheres
with the diameter of 22.0 ± 9.0 mm were used for INS-1 cell
aggregate preparation. However, the appearance of cell aggregate
was similar to that of cell aggregate without microspheres (Fig. 2
(d)e(f)). Based on this, middle and large gelatin hydrogel micro-
spheres were used for the formation of cell aggregates unless
otherwise mentioned. Fig. 2 shows the microscopic pictures of INS-
1 cell aggregates 7 or 14 days after incubation. Cell aggregates were
successfully formed in V-bottomed wells. Cell aggregates had a
fragile structure when they were prepared with larger size and
number of microspheres at the initial seeding density of
1.0  104 cells/well even 14 days after incubation (Fig. 2 (i)). On the
other hand, when the initial seeding density was 1.0  103 cells/
well, cell aggregates were successfully obtained even in the case of
larger size microspheres.
3.3. Effect of gelatin hydrogel microspheres on cell viability and
reductase activity in cell aggregates
Fig. 3 shows the ﬂuorescent images of cell aggregates after the
live/dead assay. To assess the cell viability in INS-1 cell aggregates,
the live/dead assay was conducted. At the initial seeding density of
1.0  104 cells/well, the cells in the center of microspheres-free cell
aggregates died (Fig. 3 (d)). On the other hand, the microspheres
suppressed the cell death (Fig. 3 (g)e(i)), irrespective of the size and
number of microspheres incorporated. The microspheres incorpo-
ration did not affect the cell viability in cell aggregates at the initial
seeding density of 1.0  103 cells/well (Fig. 3 (a)e(c)).
Trypan-blue exclusion test was performed to evaluate the
number of live cells in cell aggregates. Fig. 4 shows the number of
live cells 7 or 14 days after incubation. The number of live cells
showed little change for cell aggregates prepared at the initial
seeding density of 1.0  103 cells/well with incubation time. On the
other hand, the number decreased for cell aggregates at the initial
seeding density of 1.0  104 cells/well. For cell aggregates at the
initial seeding density both of 1.0 103 and 1.0 104 cells/well, the
number of live cells in cell aggregates incorporating large size and
number of gelatin hydrogel microspheres was signiﬁcantly larger
than that of cell aggregates incorporating middle microspheres and
without microspheres 7 days after incubation.
Fig. 1. Light microscopic pictures of gelatin hydrogel microspheres dispersed in the culture medium. The diameter of gelatin hydrogel microspheres is 22.0 ± 9.0 (small) (A),
46.0 ± 14.0 (middle) (B) or 82.0 ± 18.0 mm (large) (C). Scale bar is 100 mm.
Fig. 2. Light microscopic pictures of INS-1 cell aggregates 7 and 14 days after incubation with or without gelatin hydrogel microspheres. Symbols (a)e(i) correspond to those in
Table 1. Arrows indicate gelatin hydrogel microspheres. Scale bar is 500 mm.
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Fig. 3. Live/dead assay pictures of INS-1 cell aggregates with or without gelatin hydrogel microspheres 7 and 14 days after incubation. Symbols (a)e(i) correspond to those in
Table 1. Scale bar is 500 mm.
Fig. 4. Live INS-1 cell number per aggregate with or without gelatin hydrogel microspheres 7 and 14 days after incubation. (A) Cell aggregates with 1.0  101 of middle size (,) and
large size gelatin hydrogel microspheres (△) or without gelatin hydrogel microspheres (〇) at the initial seeding density of 1.0  103 cells/well. *p < 0.01, signiﬁcant against the
number of live INS-1 cells in cell aggregate without gelatin hydrogel microspheres at the corresponding time; yp < 0.05, signiﬁcant against the number of live INS-1 cells with
middle size of gelatin hydrogel microspheres at the corresponding time. (B) Cell aggregates with 1.0  102 of middle size (-), 0.5  102 of large size (:) and 1.0  102 of large size
of gelatin hydrogel microspheres (▽) or without gelatin hydrogel microspheres (C) at the initial seeding density of 1.0  104 cells/well. zp < 0.01, signiﬁcant against the number of
live INS-1 cells in cell aggregate without gelatin hydrogel microspheres at the corresponding time; xp < 0.01, signiﬁcant against the number of live INS-1 cells with middle size of
gelatin hydrogel microspheres at the corresponding time.
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Fig. 5 shows the reductase activity per INS-1 cell aggregate or
INS-1 cell 7 and 14 days after incubation with or without gelatin
hydrogel microspheres. The reductase activity per aggregate
increased with incubation time. For cell aggregates at the initial
seeding density of 1.0 103 and 1.0 104 cells/well, the activity per
aggregate incorporating large size and number of gelatin hydrogel
microspheres tended to be larger than that of cell aggregate
incorporating middle microspheres and without microspheres
(Fig. 5A and B). The proﬁle of the reductase activity per cell was the
similar to that per aggregate (Fig. 5C and D).
3.4. Effect of gelatin hydrogel microspheres on glucose-induced
insulin secretion of cell aggregates
Fig. 6 shows the insulin secretion per INS-1 cell aggregate or
INS-1 cell 7 and 14 days after incubation with or without gelatin
hydrogel microspheres. Cell aggregates with large microspheres
secreted insulin at signiﬁcantly larger amount than those with
middle microspheres and without microspheres for 14 days at the
initial seeding density of 1.0  103 cells/well. On the other hand, at
the initial seeding density of 1.0  104 cells/well, cell aggregates
with large microspheres tended to secrete insulin at larger amount
than those with middle microspheres and without microspheres,
and the decreasing tendency of insulin secretion was observed
(Fig. 6A and B). The insulin secretion per cell in aggregate incor-
porating large microspheres was also signiﬁcantly higher than that
in aggregate with middle microspheres and without microspheres
at 14 days after incubation at the initial seeding density of
1.0  103 cells/well. However, at the initial seeding density of
1.0 104 cells/well, there was no difference among cells in each cell
aggregate (Fig. 6C and D).
4. Discussion
Generally, U and V-bottomed multi-well plates or a hanging-
drop method are used to prepare cell aggregates in lab-scale
[17e20]. However, the aggregates formation depended on the
type of cells. For example, INS-1 cell aggregates did not formwhen
96-well U-bottomed or Flat-bottomed plate was used. This is
because cells adhered to the bottom surface or wall of well unless
the well was coated for anti-cell adhesion (data not shown) [13,14].
On the other hand, cell aggregates were obtained in the V-
bottomed well even without the anti-cell adhesion coating. It is
reported that cells did not remain on the wall of wells because the
V-bottomed well had too steep wall to induce cell adhesion [20].
The formation of cell aggregate depended on the size and number
Fig. 5. Reductase activity 7 and 14 days after incubation. (A) Reductase activity of INS-1 cell aggregate with 1.0  101 of middle size (,) and large size gelatin hydrogel microspheres
(△) or without gelatin hydrogel microspheres (〇) at the initial seeding density of 1.0  103 cells/well. (B) Reductase activity of INS-1 cell aggregate with 1.0  102 of middle size
(-), 0.5  102 of large size (:) and 1.0  102 of large size of gelatin hydrogel microspheres (▽) or without gelatin hydrogel microspheres (C) at the initial seeding density of
1.0  104 cells/well. (C) Reductase activity of INS-1 cell in aggregates with 1.0  101 of middle size (,) and large size gelatin hydrogel microspheres (△) or without gelatin hydrogel
microspheres (〇) at the initial seeding density of 1.0  103 cells/well. (D) Reductase activity of INS-1 cell in aggregates with 1.0  102 of middle size (-), 0.5  102 of large size (:)
and 1.0  102 of large size of gelatin hydrogel microspheres (▽) or without gelatin hydrogel microspheres (C) at the initial seeding density of 1.0  104 cells/well.
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of microspheres (Fig. 2). Cell aggregates were not completely
formed upon using larger size and number of microspheres even 14
days after incubation at the initial seeding density of 1.0 104 cells/
well. It is likely that microspheres tended to sink down to the well
bottom faster than cells because of their heavy weight, and larger
number of microspheres (0.5 or 1  102 microspheres/well) tended
to occupy the larger volume of the well bottom. Consequently, the
microspheres were ﬁrstly gathered on the bottom surface of wells
and then cells surrounded them (Supplemental Fig.1), because cells
could not sufﬁciently go through the spaces inbetween larger
number of microspheres. It is highly conceivable that heteroge-
neous distribution of cells and microspheres structurally weakened
cell aggregates. This result suggests that there is an optimal number
ratio of cells to microspheres.
In this study, gelatin was used for the material of hydrogel mi-
crospheres because of its high chemical susceptibility and
biocompatibility. Gelatin is biodegradable material and has been
extensively used for food, pharmaceutical, and medical purposes
and its biosafety has been proven through their long practical ap-
plications [21e25]. However, for the formation of more rigid cell
aggregates, it is required to modify or optimize the hydrogel mi-
crospheres to promote INS-1 cell attachment to the surface of mi-
crospheres. The coating of cell adhesion proteins, such as
ﬁbronectin, laminin, vitronectin, and collagen, is known to improve
cell adhesion to the surface of microspheres [26e28]. Isoionic point
9.0 (pI 9) gelatin has a positive charge at the physiological pH and
might promote cell adhesion because cell surfaces have a negative
charge [29,30].We evaluated INS-1 cell attachment to the surface of
low-attachment 24well plate (#3473, Corning Inc.) which had been
coated by gelatin of pI5 or 9 (weight-averaged molecular
weightx1,00,000, Nitta Gelatin Inc.), collagens, and cell adhesion
proteins. The concentration of coating solutions and coating
methods were decided according to the manufacturer's protocol.
The protocol for the coating of gelatin (pI 5 or 9) referred to that of
collagen. The gelatin of pI9, collagen type 1 (Type I-A, I-P; Nitta
Gelatin Inc./I-AC, Koken Co., Ltd., Tokyo), type 3 (PSC-3-100-05;
Nippi Inc., Tokyo, Japan), or type 4 (ASC-4-104-01; Nippi), ﬁbro-
nectin (Wako Pure Chemical Industries Ltd.), and vitronectin (Sig-
maeAldrich Company Ltd.) improved the INS-1 cells attachment
compared with gelatin of pI 5 (Supplemental Fig. 2). On the other
Fig. 6. Insulin secretion 7 and 14 days after incubation. (A) Insulin secretion per INS-1 cell aggregate with 1.0  101 of middle size (,) and large size gelatin hydrogel microspheres
(△) or without gelatin hydrogel microspheres (〇) at the initial seeding density of 1.0  103 cells/well. *p < 0.05, yp < 0.01, signiﬁcant against insulin secretion per aggregate
without gelatin hydrogel microspheres at the corresponding time. zp < 0.05, signiﬁcant against insulin secretion per aggregate with middle size of gelatin hydrogel microspheres at
the corresponding time. (B) Insulin secretion per INS-1 cell aggregate with 1.0  102 of middle size (-), 0.5  102 of large size (:) and 1.0  102 of large size of gelatin hydrogel
microspheres (▽) or without gelatin hydrogel microspheres (C) at the initial seeding density of 1.0  104 cells/well. (C) Insulin secretion per INS-1 cell in aggregates with 1.0  101
of middle size (,) and large size gelatin hydrogel microspheres (△) or without gelatin hydrogel microspheres (〇) at the initial seeding density of 1.0  103 cells/well. xp < 0.05,
signiﬁcant against insulin secretion per aggregate without gelatin hydrogel microspheres at the corresponding time. jjp < 0.05, signiﬁcant against insulin secretion per aggregate
with middle size of gelatin hydrogel microspheres at the corresponding time. (D) Insulin secretion per INS-1 cell in aggregates with 1.0  102 of middle size (-), 0.5  102 of large
size (:) and 1.0  102 of large size of gelatin hydrogel microspheres (▽) or without gelatin hydrogel microspheres (C) at the initial seeding density of 1.0  104 cells/well.
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hand, laminin (Wako Pure Chemical Industries Ltd.) did not pro-
mote the cell attachment. Taken together, the surface coating of
gelatin hydrogel microsphere by collagen, ﬁbronectin or vitronectin
might be promising to improve cell attachment and form more
rigid aggregates, although the coating onto the surface of tissue
culture plates does not represent directly that of gelatin hydrogel
microspheres.
The viability of cells in the center of cell aggregates without
microspheres was obviously bad when the initial seeding density
was 1.0 104 cells/well even 7 days after incubation (Fig. 3). On the
other hand, it is apparent that the microspheres incorporation
suppressed the cell death, although a little decrease in the cell
viability was detected, because the aggregates showed yellow color
which were mixed with green live cells and red dead cells. The
number of live cells in cell aggregates was improved by the incor-
poration of gelatin hydrogel microspheres, especially for larger size
and number ofmicrospheres (Fig. 4). It is demonstrated that oxygen
and nutrients did not supply sufﬁciently to cells present in the
center of aggregates without microspheres [9,10]. We previously
demonstrated that the incorporation of gelatin hydrogel micro-
spheres enabled MSC in their aggregates to improve the cell
viability and proliferation, and osteogenic differentiation [13,14].
We can say with certainty that the gelatin hydrogel microspheres
gave a pathway of oxygen to the cell aggregates. Especially, larger
size and number of microspheres would give more efﬁcient
pathway of oxygen to cells inside the cell aggregates than smaller
size and number of microspheres. Therefore, a large number of live
cells would remain in the cell aggregates incorporating larger size
and number ofmicrospheres. As seen in Fig. 4B, the live cell number
was notably decreased with the incubation time when the initial
seeding density was 1.0  104 cells/well. In addition, the cell
number only slightly increased compared with the cell number
seeded initially, whereas the cell number increased 5e10 folds
compared with the initial cell number at the initial seeding density
of 1.0  103 cells/well. The initial seeding density of 1.0  104 cells/
well would be too high to allow cell aggregates to grow in the V-
bottomed well. It is conceivable that the insufﬁcient space physi-
cally hindered the cell proliferation. Taken together, this result
suggests that there must be an optimal seeding density for each
culture substrate not to physically damage the cell aggregates.
It is apparent from Fig. 2 that cell number increased with in-
cubation time for cell aggregates at the initial seeding density of
1.0  103 cells/well (a-c), aggregates without microspheres (d) and
with middle microspheres (e) at the initial seeding density of
1.0  104 cells/well, because the size of aggregate increased with
incubation time. The aggregates with larger microspheres at the
initial seeding density of 1.0  104 cells/well (h, i) did not increase
the size, but the structural density seems to become higher with
the incubation time. We can think that this is because the
increasing cell number resulted in ﬁlling the spaces between ag-
gregates. However, trypan-blue staining showed that live cell
number did not increase at the initial seeding density of
1.0  103 cells/well, and live cell number decreased at that of
1.0  104 cells/well (Fig. 4). This implies that the lack of oxygen and
nutrients caused the necrosis of cells in the center of aggregate, and
the narrow bottom space of well damaged cells in aggregate. At the
initial seeding density of 1.0  103 cells/well, cell aggregates with
large microspheres secreted signiﬁcantly larger amount if insulin
than aggregates with middle microspheres or without micro-
spheres (Fig. 6A). We got the equivalent result on the insulin
secretion per cell (Fig. 6C). On the other hand, at the initial seeding
density of 1.0  104 cells/well, insulin secretion amount per
aggregate decreased with the decrease of live cell number, and the
insulin secretion amount per cell did not change with incubation
time (Fig. 6B and D). It is well known that insulin secreting cells are
susceptible to a hypoxic environment and need large amount of
oxygen to physiologically produce insulin [11,12]. In this connec-
tion, this result experimentally conﬁrms that the presence of
gelatin hydrogel microspheres could give INS-1 cells a larger
amount of oxygen to secrete insulin. As mentioned above, it is
possible that the V-bottomed well physically damaged the cell
aggregates because the well bottom area is narrow compared with
that of U-bottomed or ﬂat-bottomed well. This may be explained in
terms of the physical stress which greatly affects the proﬁle of in-
sulin secretion. The result of reductase activity was different from
that of live cell number at both initial seeding densities of 1.0  103
and 1.0  104 cells/well, namely the activity per cell and aggregate
increased with incubation time (Fig. 5). It is considered to be
difﬁcult to deﬁnitely determine the live or dead of cells by trypan
blue staining method because the method can show the cell
viability only by the damage degree of cell membrane. Cells
detected as dead cells maintained the reductase activity and then
the activity increased with incubation time. This is because the cell
number increased as mentioned above. This result implies that the
insulin secretion ability was sensitive to cell viability compared
with reductase activity.
In this study, glucose-induced insulin secretionwas evaluated as
the function of insulin secreting cell aggregates because the func-
tion is the most important for the diabetes treatment. It is known
that this function is damaged by the hypoxic environment most
seriously. The improvement of insulin secretion ability by the mi-
crospheres is important for treatment of type 1 diabetes.
Particularly, in the present study, INS-1 cell aggregate with large
gelatin hydrogel microspheres with the initial seeding density of
1.0 103 cells/well would be cell aggregates preparedwith the best
condition for treatment of type 1 diabetes, because the aggregates
secrete signiﬁcantly higher amount of insulin after the same in-
cubation time as aggregates withmiddlemicrospheres andwithout
microspheres.
Pseudo-islets artiﬁcially formed from insulin secreting cells
undergo necrosis because the cell aggregates are generally cultured
under a static condition. Lock et al. or Matta et al. used the biore-
actor for suspension culture to improve the oxygen and nutrients
transport [31,32]. The supplementation of all-trans retinoic acid or
nicotinamide to the culture medium also maintained or enhanced
the functions of pseudo-islets [33e36]. Primarily isolated islets
show a tendency of self-aggregation and the islet clumping often
causes the serious necrosis because of the lack of oxygen and nu-
trients after the islet transplantation [37e39]. To tackle this issue,
Liao et al. made islets separate to each other by their embedding
into a hydrogel [37]. Qi et al. or Aung et al. encapsulated islets into a
PVA sheet or tube not to form the clumping [38e40]. Similarly,
Onoe et al. encapsulated islets into alginate ﬁbers [41]. The gelatin
hydrogel microspheres technologymight be promising to avoid the
necrosis under the conventional static culture condition without
any devices to suppress the clumping because the microspheres
function as the pathway of oxygen and nutrients in insulin
secreting cell aggregates or islets. When the cell aggregate become
larger, the simple supplementation to the culture medium would
not reach cells in the center of aggregates sufﬁciently because of the
inherent barrier of cell aggregates. We previously reported that
gelatin hydrogel microspheres function as not only the pathway of
oxygen and nutrients, but also biological factors release carrier
[24,42e44]. If the supplementation of all-trans retinoic acid or
nicotinamide is performed from gelatin hydrogel microspheres in
cell aggregates, cells in aggregates might uniformly interact with
these factors. Furthermore, it is known that primary islets contain
cells secreting vascular endothelial growth factor-A (VEGF-A) to
regulate islet differentiation, form highly vascularized islets, and
maintain islet functions [45e47]. It is easily predicted that the
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release of VEGF from gelatin hydrogel microspheres in cell aggre-
gates would realize the artiﬁcially formed insulin secreting cell
aggregates more similar to natural islets.
The present study demonstrates that the incorporation of
gelatin hydrogel microspheres at the certain size and number could
improve the cell viability and insulin secretion function. This
technology is promising to give insulin secreting cell aggregates a
better condition for their functional improvement, although more
optimization of microspheres is needed in the future.
5. Conclusions
INS-1 cell aggregates with or without gelatin hydrogel micro-
spheres were formed. Cell viability and glucose-induced insulin
secretion of cell aggregates were improved by the incorporation of
microspheres especially at the larger size and number.
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